.
.
.
Analytical Method Development and Validation Service

đ§Ź INTRODUCTION
At ResolveMass Laboratories Inc., our Analytical Method Development and Validation Service is designed to deliver accurate, reproducible, and regulatory-compliant analytical solutions for complex pharmaceutical, biopharmaceutical, and life science applications. With hands-on scientific experience, advanced instrumentation, and a deep understanding of global regulatory expectations, we help organizations generate reliable analytical data generation using proven techniques such as HPLC analysis and mass spectrometry-based methodologies to strengthen product development, regulatory submissions, and long-term quality assurance.
â KEY VALUE PROPOSITION
- Scientifically sound and lifecycle-based analytical methods
- Full compliance with ICH, USP, FDA, and EMA guidelines
- Methods tailored to your molecule, matrix, and regulatory pathway
- Robust documentation suitable for audits and submissions
- Experienced analytical scientists with real-world laboratory expertise
đŹ ANALYTICAL METHOD DEVELOPMENT SERVICES
Analytical Method Development Expertise
ResolveMass Laboratories Inc. specializes in the development of fit-for-purpose analytical methods that ensure precision, specificity, and robustness throughout the product lifecycle. Our scientists apply scientific risk assessment and experimental design while leveraging advanced platforms such as high-resolution mass spectrometry (HRMS) analysis to address complex analytical challenges under real manufacturing and stability conditions.
- HPLC, UHPLC, and LC-MS method development
- Assay and impurity profiling methods
- Stability-indicating method development
- Dissolution and release testing methods
- Residual solvent and elemental impurity analysis
- Forced degradation and stress testing studies
đ§ž ANALYTICAL METHOD VALIDATION SERVICES
Regulatory-Compliant Method Validation
Our Analytical Method Development and Validation Service includes full validation studies conducted in accordance with ICH Q2(R1/R2), USP <1225>, and regulatory authority expectations. For high-risk impurities and evolving regulatory concerns, our validation strategies integrate specialized testing such as nitrosamine analysis to ensure patient safety and regulatory readiness. Each validation is scientifically justified, statistically evaluated, and fully documented to withstand regulatory review and inspections.
- Accuracy, precision, and intermediate precision
- Specificity and selectivity
- Linearity and range
- Detection and quantitation limits (LOD/LOQ)
- Robustness and system suitability
- Method transfer and verification support
đ REGULATORY & QUALITY COMMITMENT
Built for Global Regulatory Acceptance
ResolveMass Laboratories Inc. operates with a quality-driven mindset, ensuring every analytical method aligns with current regulatory guidance and data integrity principles. Our validation protocols, reports, and raw data packagesâsupported by advanced analytical technologies including LC-MSâbased impurity profilingâare prepared to support IND, NDA, ANDA, and MA submissions, as well as internal audits and regulatory inspections.
đ INDUSTRIES WE SERVE
Industries & Applications
- Pharmaceutical and generic drug manufacturers
- Biopharmaceutical and biologics developers
- Contract development and manufacturing organizations (CDMOs)
- Specialty chemicals and intermediates
- Research and innovation-focused life science companies
â Why RESOLVEMASS LABORATORIES INC. A Trusted Partner in Analytical Science
ResolveMass Laboratories Inc. is trusted by clients who value scientific rigor, transparency, and dependable results. Our analytical scientists bring extensive hands-on laboratory experience across platforms such as HPLC analysis, GC-MS, and HRMS, applying a problem-solving mindset to every project. We donât just validate methodsâwe build analytical strategies that support long-term product success and regulatory confidence.
Partner with Experts in Analytical Method Development
When accuracy, compliance, and scientific credibility matter, ResolveMass Laboratories Inc. delivers proven solutions through its Analytical Method Development and Validation Service. Our expert-driven approach ensures your analytical methods are reliable, defensible, and ready for regulatory scrutinyâtoday and throughout the product lifecycle.
Request a Consultation – Contact page
âFrequently Asked Questions
Analytical method validation confirms that a testing procedure consistently produces accurate and reliable results for its intended purpose. It involves evaluating parameters such as accuracy, precision, specificity, linearity, and robustness. The goal is to ensure the method performs effectively under defined laboratory conditions and meets regulatory expectations.
Analytical method development focuses on designing and optimizing a testing procedure to measure a specific analyte accurately. Validation, on the other hand, proves that the developed method performs consistently and reliably according to predefined criteria. Development builds the method, while validation confirms its suitability for routine use.
Phase 3 method validation is conducted during late-stage clinical development or before commercial manufacturing. It ensures the analytical method is fully validated, highly robust, and suitable for long-term routine testing. At this stage, methods must meet strict regulatory requirements for product approval and commercialization.
Analytical methods are validated to ensure test results are accurate, consistent, and scientifically defensible. Validation reduces the risk of errors, supports regulatory compliance, and builds confidence in data used for quality control and decision-making. It also ensures product safety and efficacy throughout its lifecycle.
LOD (Limit of Detection) is the lowest amount of analyte that can be detected but not necessarily quantified accurately. LOQ (Limit of Quantitation) is the lowest level that can be measured with acceptable precision and accuracy. Both parameters define the sensitivity of an analytical method.
Challenges in analytical method development include achieving adequate specificity, sensitivity, and robustness for complex samples. Variability in raw materials, matrix interferences, and evolving regulatory expectations can complicate method optimization. Balancing performance, cost, and scalability is also a key challenge.
Reference
- Ravisankar, P., Gowthami, S., & Devlala Rao, G. (2014). A review on analytical method development. Indian Journal of Research in Pharmacy and Biotechnology, 2(3), 1183â1195. Retrieved from https://www.ijrpb.com/issues/Volume%202_Issue%203/ijrpb%202(3)%209%20ravisankar%202%201183-1195.pdf
- Rina, R., Baile, M., & Jain, A. (2021). A review: Analytical method development and validation. Systematic Reviews in Pharmacy, 12(8), 450â454. Retrieved from https://www.sysrevpharm.org/articles/a-review-analytical-method-development-and-validation.pdf